Carisma Therapeutics, Inc.6月11日成交额为2355.10万美元

市场透视06-12

美东时间2025年6月11日，Carisma Therapeutics, Inc.（CARM.US）成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.（CARM.US）于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2542540625?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-12 09:27","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2542540625","market":"us","top_or_hot":-1,"title":"Carisma Therapeutics, Inc.6月11日成交额为2355.10万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年6月11日，Carisma Therapeutics, Inc.（CARM.US）成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.（CARM.US）于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Carisma Therapeutics, Inc.6月11日成交额为2355.10万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCarisma Therapeutics, Inc.6月11日成交额为2355.10万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-12 09:27 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年6月11日，Carisma Therapeutics, Inc.（CARM.US）成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.（CARM.US）于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","article_id":"2542540625","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612092757a4a43111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2542540625","pubTimestamp":1749691671,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年6月11日，Carisma Therapeutics, Inc.成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","LENZ":"Therapeutics","BK4539":"次新股","CARM":"Carisma Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"Carisma Therapeutics, Inc. turnover of $23.551 million on June 11","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CARM":1,"LENZ":1},"content_text":"美东时间2025年6月11日，Carisma Therapeutics, Inc.（CARM.US）成交额为2355.10万美元，成交额较昨日减少96.10%，当日成交量为3777.01万股。Carisma Therapeutics, Inc.（CARM.US）于2025年6月11日跌45.66%，报0.603美元，该股过去5个交易日涨242.73%，年初至今涨43.96%，过去60日涨45.7%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-11|2355.10万|-96.10%|3777.01万|#|2025-06-10|6.04亿|7484.90%|7.23亿|#|2025-06-09|796.62万|22376.82%|3664.16万|#|2025-06-06|3.54万|-50.30%|18.36万|#|2025-06-05|7.13万|-19.80%|38.17万|CARISMA Therapeutics Inc 是一家临床阶段的细胞治疗公司，致力于利用 Carisma 专有的嵌合抗原受体巨噬细胞和单核细胞细胞工程平台开发治疗癌症和其他严重疾病的变革性免疫疗法。公司曾创建了一个全面的细胞治疗平台，使工程巨噬细胞和单核细胞的治疗用途成为可能，巨噬细胞和单核细胞属于白细胞的一个亚群，称为髓系细胞。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2542540625","isCrawlerRequest":true}